By Canadian Press

Single-payer pharmacare would cost billions more a year, but save economy money: PBO

Oct 12, 2023 | 8:20 AM

OTTAWA — The parliamentary budget officer says a single-payer universal drug plan would cost the federal and provincial governments $11.2 billion in the first year, and $13.4 billion in five years.

The PBO’s report released today provides an estimate for the cost of a pharmacare program between 2024-25 and 2027-28.

It calculates the incremental cost of the program, taking into account current spending by governments on public drug plans as well as revenue that would be generated from co-pays under a pharmacare plan.

The Liberals have promised to table pharmacare legislation this fall as part of the supply-and-confidence deal the government struck with the NDP.

The PBO’s report finds that while the public sector would spend more on drugs, the implementation of a pharmacare plan would lead to economy-wide savings. 

Court proceedings

Drugs and weapons bust in Stanley Mission, results in two year sentence

18h ago

health care

La Loche recipient of new portable blood analyzer, printer kit

19h ago

Crime

Dangerous driving report at Red Wing, leads to arrest of man with gun

22h ago

The PBO estimates cost savings on drug expenditures of $1.4 billion in 2024-25, with that figure increasing to $2.2 billion by 2027-28.

This report by The Canadian Press was first published Oct. 12, 2023.

The Canadian Press